INS and metabolic disease: Intermittent fasting/exercise‐related elevated serum irisin has been connected to improved metabolic health, insulin signaling, glucose homeostasis, and other glycemic profile in animal STZ‐models of diabetes, making it a prospective target in the management of metabolic diseases.